AAAAAA
Results:
1-14
|
Results: 14
Authors:
VANTELLINGEN O
SCHAAF LJ
PUNT CJA
AWADA A
VANDERVALK M
HENRAR REC
WAGENER DJT
PICCART MJ
NOOIJEN WJ
BEIJNEN JH
Citation: O. Vantellingen et al., IN-VITRO AND IN-VIVO BONE-MARROW TOXICITY ASSAYS IN THE CLINICAL DEVELOPMENT OF NEW DRUGS - CARZELESIN AS AN EXAMPLE, Annals of oncology, 9, 1998, pp. 204-204
Authors:
ROTHENBERG ML
KUHN JG
SCHAAF LJ
ECKHARDT SG
VILLALONACALERO MA
PETIT RG
MILLER LL
ELFRING GL
MURPHY TC
VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-I AND PHARMACOKINETIC STUDY OF INTRAVENOUS IRINOTECAN (CPT-11) ADMINISTERED ONCE EVERY 2 WEEKS + - G-CSF/, Annals of oncology, 9, 1998, pp. 240-240
Authors:
ROTHENBERG ML
KUHN JG
SCHAAF LJ
DRENGLER RL
ECKHARDT SG
VILLALONACALERO MA
HAMMOND L
MILLER LL
PETIT RG
ROWINSKY EK
VONHOFF DD
Citation: Ml. Rothenberg et al., ALTERNATIVE DOSING SCHEDULES FOR IRINOTECAN, Oncology, 12(8), 1998, pp. 68-71
Authors:
VANTELLINGEN O
PUNT CJA
AWADA A
WAGENER DJT
PICCART MJ
GROOT Y
SCHAAF LJ
HENRAR REC
NOOIJEN WJ
BEIJNEN JH
Citation: O. Vantellingen et al., A CLINICAL PHARMACOKINETICS STUDY OF CARZELESIN GIVEN BY SHORT-TERM INTRAVENOUS-INFUSION IN A PHASE-I STUDY, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 377-384
Authors:
VANTELLINGEN O
NOOIJEN WJ
SCHAAF LJ
VANDERVALK M
VANASPEREN J
HENRAR REC
BEIJNEN JH
Citation: O. Vantellingen et al., COMPARATIVE PHARMACOLOGY OF THE NOVEL CYCLOPROPYLPYRROLOINDOLE-PRODRUG CARZELESIN IN MICE, RATS, AND HUMANS, Cancer research, 58(11), 1998, pp. 2410-2416
Authors:
SLATTER JG
SU P
SAMS JP
SCHAAF LJ
WIENKERS LC
Citation: Jg. Slatter et al., BIOACTIVATION OF THE ANTICANCER AGENT CPT-11 TO SN-38 BY HUMAN HEPATIC-MICROSOMAL CARBOXYLESTERASES AND THE IN-VITRO ASSESSMENT OF POTENTIAL-DRUG INTERACTIONS, Drug metabolism and disposition, 25(10), 1997, pp. 1157-1164
Authors:
ROTHENBERG ML
ECKARDT JR
KUHN JG
BURRIS HA
NELSON J
HILSENBECK SG
RODRIGUEZ GI
THURMAN AM
SMITH LS
ECKHARDT SG
WEISS GR
ELFRING GL
RINALDI DA
SCHAAF LJ
VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-II TRIAL OF IRINOTECAN IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1128-1135
Authors:
SHAEFER MS
ROSSI SJ
MCGUIRE TR
SCHAAF LJ
COLLIER DS
STRATTA RJ
Citation: Ms. Shaefer et al., EVALUATION OF THE PHARMACOKINETIC INTERACTION BETWEEN CIMETIDINE OR FAMOTIDINE AND CYCLOSPORINE IN HEALTHY-MEN, The Annals of pharmacotherapy, 29(11), 1995, pp. 1088-1091
Authors:
VANTELLINGEN O
PELS EM
HENRAR REC
SCHAAF LJ
PADBURY GE
BEIJNEN JH
NOOIJEN WJ
Citation: O. Vantellingen et al., FULLY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CARZELESIN (U-80,244) AND METABOLITES (U-76,073 ANDU-76,074) IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 652(1), 1994, pp. 51-58
Authors:
STRONG ML
SCHAAF LJ
PANKASKIE MC
ROBINSON DH
Citation: Ml. Strong et al., SHELF-LIVES AND FACTORS AFFECTING THE STABILITY OF MORPHINE-SULFATE AND MEPERIDINE (PETHIDINE) HYDROCHLORIDE IN PLASTIC SYRINGES FOR USE INPATIENT-CONTROLLED ANALGESIC DEVICES, Journal of clinical pharmacy and therapeutics, 19(6), 1994, pp. 361-369
Authors:
SCHAAF LJ
Citation: Lj. Schaaf, HERSCHEL,JOHN PHOTOGRAPHY AND THE CAMERA-LUCIDA, Transactions of the Royal Society of South Africa, 49, 1994, pp. 87-102
Authors:
SCHAAF LJ
Citation: Lj. Schaaf, HERSCHEL,JOHN PHOTOGRAPHY AND THE CAMERA-LUCIDA, Transactions of the Royal Society of South Africa, 49, 1994, pp. 87-102
Authors:
SCHAAF LJ
Citation: Lj. Schaaf, TALBOT,HENRY,FOX THE 'PENCIL OF NATURE' - A REVISED CENSUS OF ORIGINAL COPIES, History of photography, 17(4), 1993, pp. 388-396
Authors:
HOIE EB
HALL MC
SCHAAF LJ
Citation: Eb. Hoie et al., EFFECTS OF INJECTION SITE AND FLOW-RATE ON THE DISTRIBUTION OF INJECTED SOLUTIONS IN AN EXTRACORPOREAL MEMBRANE-OXYGENATION CIRCUIT, American journal of hospital pharmacy, 50(9), 1993, pp. 1902-1906
Risultati:
1-14
|